medical congresses

Sales & Marketing

Field medical education before launch is linked to greater launch success, improving treatment adoption by up to 50%.

Sales & Marketing

Overview

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.